Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion type Assertion NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_head.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion description "[Among them, MELK correlated with malignancy grade in astrocytomas and represents a therapeutic target for the management of the most frequent brain tumors in adult and children.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_provenance.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion evidence source_evidence_literature NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_provenance.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion SIO_000772 17960622 NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_provenance.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion wasDerivedFrom befree-20140225 NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_provenance.
- NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_assertion wasGeneratedBy ECO_0000203 NP616006.RATpfb-fO03wbniaLmle9McYy653QNlkd32FQPKOgW7TA130_provenance.